Asbury Automotive Group completes acquisition of Herb Chambers Companies

Asbury Automotive Group (ABG) has completed its $1.45 billion acquisition of The Herb Chambers Companies, adding 33 dealerships and entering the Northeast market, a strategic move expected to diversify its geographic footprint. However, this expansion comes amidst recent challenges, including a JPMorgan downgrade to Underweight due to increased leverage from M&A and execution risks, a 12.67% stock price decline over the past week, and a Q1 2025 revenue miss despite an EPS beat. Asbury plans to reduce leverage over the next 18-24 months and invest $250 million in capital expenditures for 2025-2026.

Analysis

Asbury Automotive Group (ABG) has executed a significant strategic expansion by completing its $1.45 billion acquisition of The Herb Chambers Companies (HCC), a move that adds 33 dealerships and $3.2 billion in 2024 revenue while marking the company's entry into the Northeast market. The transaction is financed through credit facilities, mortgage proceeds, and cash, with a substantial $750 million allocated to goodwill. However, this geographic diversification comes amid considerable headwinds and market skepticism. JPMorgan has downgraded ABG to Underweight, citing concerns over increased leverage from the acquisition and potential execution risks associated with new software rollouts and other operational initiatives. This cautious sentiment is mirrored in the stock's recent 12.67% weekly decline and mixed first-quarter 2025 results, where an adjusted EPS beat of $6.82 was overshadowed by a revenue miss of $4.1 billion against a $4.35 billion estimate. While Asbury's management has committed to a deleveraging plan over the next 18-24 months and highlights resilience in its high-margin parts and service segment (up 5% in gross profit), the decline in used vehicle units and the challenges of integrating a major acquisition present tangible risks to the company's otherwise solid fundamentals, which include a P/E ratio of 11.01 and an EV/EBITDA of 8.32.

Key Decisions for Investors

• Investors should closely monitor Asbury's deleveraging progress over the next 18-24 months, as the increased leverage from the acquisition was a key driver for the recent JPMorgan downgrade.
• While the acquisition expands the top line, pay close attention to management's execution on integrating Herb Chambers and rolling out new operational systems, as these were flagged as specific risks.
• The attractive valuation, with a P/E ratio of 11.01, must be weighed against the negative sentiment reflected in the recent stock price decline and the fundamental pressure from a Q1 revenue miss.
• Performance in the high-margin parts and service segment should be tracked as a key indicator of underlying profitability, potentially offsetting weakness in vehicle sales during the integration period.